RHO and melanoma: Another report indicates that the treatment of metastatic mouse melanoma cells with simvastatin and fluvastatin inhibits cell growth and metastasis via suppression of matrix metalloproteinases (MMPs), very late antigens (VLAs) and Rho prenylation, which are crucial for cell cycle progression and cell motility.